Latest
2581 stories · page 27 of 216
Berenberg lifts Antofagasta to buy after copper sell-off opens the door
Analysts see 16% upside in the Chilean miner, calling the recent share weakness a compelling entry point
Citi sticks with $15,000 copper target as bullish forces outweigh US tariff risk
The bank sees structural, cyclical and strategic tailwinds carrying the metal higher into 2027, offsetting American trade headwinds
Roche sequencer poses little threat to Oxford Nanopore, expert tells Citi
A genomics specialist hosted by the bank backs Oxford Nanopore's position and rates it above rival Pacific Biosciences
AstraZeneca breast cancer drug fails trial but Citi keeps buy rating
Analysts say the SERENA-4 setback for camizestrant does little damage and maintain their £178 target price on the shares
UK food inflation set to climb despite calmer global grain markets
Shore Capital says a calming USDA harvest update will not stop UK food prices rising towards 5% by 2027
